Ixekizumab vs. Guselkumab in Patients With Plaque Psoriasis Ixekizumab vs. Guselkumab in Patients With Plaque Psoriasis

This phase IV study compared the efficacy of ixekizumab and guselkumab in patients with moderate-to-severe plaque psoriasis. Did one demonstrate superiority over the other?The British Journal of Dermatology

Source: Medscape Today Headlines - July 7, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news